The Journal of Practical Medicine ›› 2022, Vol. 38 ›› Issue (21): 2635-2638.doi: 10.3969/j.issn.1006⁃5725.2022.21.001

• Coronavirus(COVID-19) •     Next Articles

Application of digital therapeutics in the treatment of novel Coronavirus sequelae

XIE Youcheng*,KANG Yinnan,LI Chuyi,ZHENG Ying,ZHANG Jiucong,YU Xiaohui.   

  1. Department of Gastroenterology,the 940 Hospi⁃ tal of Joint Service Support Forces of the Chinese People′s Liberation Army,Lanzhou 730050,China;*The First Clinical Medical School,Gansu University of Chinese Medicine,Lanzhou 730000,China 

  • Online:2022-11-10 Published:2022-11-10
  • Contact: YU Xiaohui E⁃mail:yuxiaohui@126.com

Abstract:

Post⁃covid⁃19 syndrome(PCS)is a condition in which some patients suffer from persistent respiratory,motor,psychosomatic and other dysfunctional sequelae that cannot be explained by other diagnoses. Traditional forms of rehabilitation are poorly adhered to and costly. Therefore,how to reduce the burden of disease and increase the cure rate of PCS has become a key challenge to be addressed. In recent years,digital therapies with their excellent safety,compliance and affordability,have opened new opportunities for the treatment of PCS patients and are potential candidates for improving the outcome of PCS treatment. Currently,early clinical studies have reported the unique benefits of digital therapies in the treatment of PCS in both single and combination thera⁃ pies. Taken together,the aim of this article is to review the recent clinical trials and applications of digital thera⁃ pies in PCS and to discuss their safety and efficacy in order to provide some reference for clinical application.

Key words:

post?covid?19 syndrome, digital therapy, intervention research, rehabilitation treatment